神经翻膜器件市场份额，规模，趋势，行业分析报告，由产品（凝块钉，抽吸/抽吸装置，血管圈）;通过地区使用终用（医院，急诊诊所，外科手术中心）;分部预测，2021 - 2028

Report Summary

全球神经脱层苗条的设备市场在2020年的635.4百万美元估价，预计预测期内的复合年增长率为6.7％。增加急性缺血性心脏冲程的发病率，有缺陷的生活方式，加上越来越多的吸烟者和饮酒者，并且老年龄较高的人口上升是对神经脱髓球菌器件市场增长的关键因素。这种装置用于检索脑神经血管血管中的血液凝块。

Know more about this report:请求样本页面

这些程序改善了患者结果并降低了患者死亡率，因此被认为是心脏中风的优选治疗选择。急性缺血性中风更严重，常见的所有笔画，特别是在老年人中，与男性相比，妇女经常发生。根据英国英国中风协会的市场估计，在英国，每年报告超过10万次讲课，10人在10人中有出血，过早死亡。

Industry Dynamics

增长司机
Stroke or heart attack is the most common form of casualty across the globe, favoring the adoption of the concerned product. According to the estimates of the WHO, in 2016, around 15.1 million deaths were occurred due to stroke. Moreover, according to the Center for disease and control, over 87 percent of strokes were ischemic in the U.S. alone. This is expected to drive market growth for neurothrombectomy devices.

在同一位的基础上，为了进一步证实论点，西南医疗中心发布，每年约有79.5万人患有中风。因此，预计缺血性心脏病患病率的上升率是推动这种神经脱髓鞘装置的采用。

此外，一些政府倡导，以传播意识和预防心脏抚摸。例如，Wisewans计划由美国的CDC启动，以尽量减少中风的风险，促进健康的生活方式。这些方案在低收入小组人口中针对未保险的妇女。因此，预计这些举措将提供对市场中风的不良影响的认识。

神经脱髓球菌器件市场Report Scope

该市场主要根据产品，最终使用和地区进行分段。

By Product	By End-Use	By Region
Clot Retrievers Aspiration/Suction Devices 血管粪便	Hospitals Emergency Clinics 流动的杂志ical Centers	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太（日本，中国，印度，马来西亚，印度尼西亚，韩国） Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:请求样本页面

Insight by Product

Based on the product, the global market for neurothrombectomy devices is bifurcated into clot retrievers, aspiration/suction devices, and vascular snares. In 2020, the clot retriever segment accounted for the largest revenue share. It is mostly used for removing blood clots from the cerebral arteries. Neurothrombectomy devices industry’s product segment’s high share is attributed to the rising prevalence of ischemic heart diseases and new product launches. Moreover, rising cases of blood-related hereditary disorders also favoring the segment’s growth for neurothrombectomy devices.

However, the aspiration devices segment is expected to register the highest growth rate over the projected period, owing to its preference among surgeons. The rise in neurothrombectomy devices and increasing old age population also supplementing the segment’s growth. Moreover, such devices vacuum clots from blood vessels and re-vascularize large occlusions with high accuracy.

最终用途的洞察

基于最终用途，全球神经脱层切除术设备的市场分叉进入医院，急诊诊所和外科手术中心。2020年，医院市场分部占全球神经脱层苗条术风险的最大收入份额。这是因为，由于高级医疗设施和熟练的外科医生，医院是患者的其他医疗设施。yabo娱乐vip此外，医院与保险公司合作，使患者更容易获取其医疗保险。

However, the ASCs market segment is projected to register a lucrative growth rate over the projected period. The rising preference of patients towards ASCs is attributed to its low treatment cycle time, since a significant number of out-patient surgeries are performed in ASCs. Such low waiting time and patient outcome favoring the growth of the market segment for neurothrombectomy devices.

Geographic Overview

地理位置上，神经脱髓鞘的全球市场分叉进入北美，亚太地区，欧洲，拉丁美洲和MEA。北美是欧洲和亚太地区之后最大的收入贡献者。2020年，欧洲地区占全球神经大学设备市场的32％以上。

Regional factors responsible for such market growth include enhanced risk of ischemic heart stroke in the region, rising cases of hemorrhagic, consumer’s preference towards minimally invasive surgeries, and rising funding towards research and development. According to the estimates of the EM Consult, around 1.1 million people suffer from stroke, coupled with the product launch of innovative products.

Competitive Insight

The prominent market players operating in the neurothrombectomy devices industry are Medtronic, Stryker Corporation, Acandis GmbH, Stryker Corporation, Phenox GmbH, Penumbra Inc., and Vesalio. The companies in the market are focusing on product launches to stay competitive in the market for neurothrombectomy devices.

For instance, in 2019, August Stryker Corporation introduced Sonopet iQ ultrasonic aspirator system. Technology was designed to increase power with customized control and precision. The launch would help company to expand its product portfolio in the market for neurothrombectomy devices.